๐Ÿ‡ฏ๐Ÿ‡ต ่…ŽๆฉŸ่ƒฝใจๅ…จ่บซใฎๅฅๅบทใซ้–ขใ‚ใ‚‹็”Ÿไฝ“่ชฟ็ฏ€ใƒกใ‚ซใƒ‹ใ‚บใƒ ใฎๆฆ‚่ฆ

ืขื‘ืจื™ืช,ย Spanish โ€“ Espaรฑol,ย ะ ัƒััะบะธะน,ย Deutsch,ย English, ๆ—ฅๆœฌ่ชž.

ๆ…ขๆ€ง่…Ž่‡“็—…ใฏไธ€่ˆฌใซๆฉŸ่ƒฝไฝŽไธ‹ใฎ้€ฒ่กŒใจใ—ใฆ็†่งฃใ•ใ‚Œใพใ™ใŒใ€่ฟ‘ๅนดใฎ็ ”็ฉถใงใฏใ€็”Ÿไฝ“ๅ†…ใฎ่ชฟ็ฏ€ใƒป็ถญๆŒๆฉŸๆง‹ใŒ้‡่ฆใชๅฝนๅ‰ฒใ‚’ๆžœใŸใ™ใ“ใจใŒ็คบๅ”†ใ•ใ‚Œใฆใ„ใพใ™ใ€‚

ๆœฌ็จฟใงใฏใ€ใ‚จใƒใƒซใ‚ฎใƒผไปฃ่ฌใ€็ดฐ่ƒžไฟ่ญทใจใ‚ฏใƒชใ‚ขใƒฉใƒณใ‚นใ€่ก€ๆตใจๅ…จ่บซ็’ฐๅขƒใจใ„ใ†ไธ‰ใคใฎ่ปธใ‹ใ‚‰ใ€่…ŽๆฉŸ่ƒฝใ‚’ๆ”ฏใˆใ‚‹ใƒกใ‚ซใƒ‹ใ‚บใƒ ใ‚’ๆ•ด็†ใ—ใพใ™ใ€‚

๏ผˆโ€ป ็”Ÿไฝ“ใฎๅ†…ๅœจ็š„ใช่ชฟ็ฏ€ๆฉŸๆง‹ใซ็€็›ฎใ—ใŸๆฆ‚ๅฟตใƒขใƒ‡ใƒซ๏ผ‰


The following table summarizes key biological pathways discussed in the literature.


๐Ÿ“Š Table: Key Biological Pathways in Kidney Function and Their Potential Modulation

PathwayPrimary Role in Kidney FunctionPotential Modulation (Natural Interventions)Additional Organs Affected
AMPK โ†’ SIRT1 โ†’ PGC-1ฮฑMitochondrial biogenesis; protection of podocytes and tubular cellsResveratrol; light physical activity (e.g., walking); intermittent fastingHeart, brain, liver, lungs
Nrf2โ€“Keap1Antioxidant defense; detoxification; inflammation reductionSulforaphane (broccoli sprouts); curcuminGut barrier, liver, heart, brain, lungs
Mitophagy / Autophagy + TFEBRemoval of damaged mitochondria and cellular debrisUrolithin A (pomegranate derivatives); resveratrol; sulforaphaneLiver, heart, brain, lungs, gut
FGF23โ€“KlothoPhosphateโ€“calcium balance; anti-fibrotic; anti-aging effectsVitamin D3 (controlled dosing); resveratrol; sulforaphane; physical activityHeart (reduced calcification), brain, lungs
Gutโ€“Kidney AxisReduction of systemic inflammation; decreased toxin load (e.g., TMAO); gut barrier supportSulforaphane; urolithin A; targeted probioticsGut, liver, heart, brain, lungs
HPT Axis (Thyroid)Regulation of metabolic rate and mitochondrial activity (T3)Resveratrol; sulforaphane; physical activityHeart, brain, liver, lungs
mTORC1Regulation of cellular growth; chronic overactivation linked to fibrosisMild inhibition via AMPK activation (resveratrol; sulforaphane)Heart, liver, skeletal muscle
Wnt/ฮฒ-cateninChronic activation linked to fibrosis and podocyte injuryResveratrol; curcumin; sulforaphaneHeart, liver, lungs, brain
NO / eNOSVascular dilation; improved renal blood flow; endothelial protectionPolyphenols (e.g., resveratrol); plant-derived compounds (e.g., Opuntia ficus-indica)Heart, brain, lungs, liver, gut
Irisin / FNDC5Myokine-mediated protection of kidney cells; podocyte supportPhysical activity; PGC-1ฮฑ activationBrain (BDNF), heart, liver, lungs
PPARฮฑFatty acid oxidation in renal cells; prevention of lipotoxicityResveratrol; sulforaphane; physical activityLiver, heart, brain
Epigenetic RegulationLong-term gene expression modulation; cellular memorySIRT1 activation (resveratrol); sulforaphane; physical activitySystem-wide
Vitamin D / VDRDirect activation of Klotho; podocyte protection; anti-inflammatory effectsVitamin D3 (monitored dosing); controlled sun exposureBrain, heart, lungs, gut, bone

ๆœฌ่กจใฏๆ•™่‚ฒ็š„ใƒปๆฆ‚ๅฟต็š„ใชๆ•ด็†ใ‚’็›ฎ็š„ใจใ—ใฆใŠใ‚Šใ€็‰นๅฎšใฎๆฒป็™‚ใ‚’ๆŽจๅฅจใ™ใ‚‹ใ‚‚ใฎใงใฏใ‚ใ‚Šใพใ›ใ‚“ใ€‚

ืขื‘ืจื™ืช, Spanish โ€“ Espaรฑolะ ัƒััะบะธะนDeutschEnglish


๐Ÿ“š ๅ‚่€ƒๆ–‡็Œฎ๏ผˆReferences๏ผ‰

๐Ÿ”‹ ใ‚จใƒใƒซใ‚ฎใƒผไปฃ่ฌใจๅ†็”Ÿ๏ผˆEnergy and Regeneration๏ผ‰

  1. Hallan S, Sharma K. The role of mitochondria in diabetic kidney disease. Nat Rev Nephrol.
  2. Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nat Rev Nephrol.
  3. Hardie DG. AMPK: a key regulator of energy balance in the kidney. Physiol Rev.
  4. Cantรณ C, Auwerx J. Targeting sirtuin 1 to improve metabolism. Nat Rev Drug Discov.
  5. Hasegawa K et al. SIRT1 protects against oxidative stress in kidney disease. J Am Soc Nephrol.
  6. Scarpulla RC. PGC-1ฮฑ and mitochondrial biogenesis. Cell Metab.
  7. Kume S et al. Role of nutrient-sensing pathways in diabetic nephropathy. J Am Soc Nephrol.
  8. Martins R et al. FOXO proteins and aging. Aging Cell.
  9. Cheng Z et al. SIRT1/FOXO pathway in renal protection. Kidney Int.
  10. Verdin E. NADโบ metabolism and aging. Science.

๐Ÿ›ก๏ธ ็ดฐ่ƒžไฟ่ญทใจใ‚ฏใƒชใ‚ขใƒฉใƒณใ‚น๏ผˆProtection and Clearance๏ผ‰

  1. Yamamoto M et al. The KEAP1โ€“NRF2 system: a master regulator of oxidative stress. Physiol Rev.
  2. Ruiz S et al. Targeting the Nrf2 pathway in kidney disease. Kidney Int.
  3. Ding Y, Choi ME. Autophagy in diabetic nephropathy. J Endocrinol.
  4. Livingston MJ et al. Autophagy in acute kidney injury and repair. J Clin Invest.
  5. Kimura T et al. Autophagy and the kidney. Nat Rev Nephrol.
  6. Pickles S et al. Mitophagy and mitochondrial quality control. Nat Rev Mol Cell Biol.
  7. Settembre C et al. TFEB links autophagy to lysosomal biogenesis. Science.
  8. Mizushima N. Autophagy: process and function. Genes Dev.

๐ŸŒŠ ็’ฐๅขƒใƒป่ก€ๆตใƒปๅ…จ่บซ็›ธไบ’ไฝœ็”จ๏ผˆEnvironment, Flow, and Systemic Interaction๏ผ‰

  1. Fรถrstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J.
  2. Vanhoutte PM et al. Endothelial dysfunction and vascular disease. Acta Physiol.
  3. Crowley SD, Coffman TM. The inextricable role of the kidney in hypertension. J Clin Invest.
  4. Mezzano SA et al. Renin-angiotensin system and renal fibrosis. Kidney Int Suppl.
  5. Fine LG, Norman JT. Chronic hypoxia as a mechanism of kidney disease progression. Kidney Int.
  6. Haase VH. Hypoxia-inducible factors in kidney disease. J Am Soc Nephrol.
  7. Ruiz-Ortega M et al. TGF-ฮฒ signaling in renal fibrosis. Nat Rev Nephrol.
  8. Evenepoel P et al. The gut-kidney axis. Nat Rev Nephrol.
  9. Vaziri ND et al. CKD alters gut microbiome and toxin generation. Kidney Int.
  10. Tang WHW et al. Gut microbiota and cardiovascular disease (TMAO pathway). N Engl J Med.

๐Ÿ”น ๆ…ขๆ€ง่…Ž็–พๆ‚ฃใŠใ‚ˆใณ็ทš็ถญๅŒ–ใซ้–ขใ™ใ‚‹่ฃœ่ถณๆ–‡็Œฎ๏ผˆCKD and Fibrosis๏ผ‰

  1. Kalantar-Zadeh K et al. Chronic kidney disease. Lancet.
  2. Levin A et al. Kidney disease: global burden and management. Lancet.
  3. Ruiz S, Pergola PE, Zager RA. Targeting oxidative stress in CKD. Kidney Int.
  4. Nath KA. Tubulointerstitial changes as a major determinant in CKD. Kidney Int.
  5. Friedman SL et al. Mechanisms of fibrosis across organs. J Clin Invest.



ใ”่ณชๅ•ใฏใ‚ใ‚Šใพใ™ใ‹๏ผŸ

ไปฅไธ‹ใฎ้€ฃ็ตกๅ…ˆใ‚’้€šใ˜ใฆใ€ใƒคใƒญใƒณใƒปใƒžใƒซใ‚ดใƒชใƒณใซใŠๅ•ใ„ๅˆใ‚ใ›ใใ ใ•ใ„ใ€‚

    ืฉืžื™ Name:


    ื˜ืœืคื•ืŸ phone:


    ื“ื•ื"ืœ (ื›ื“ื™ ืฉืื•ื›ืœ ืœื”ืฉื™ื‘ ืœืš ืžื›ืœ ืžืงื•ื ื‘ืขื•ืœื) Email:


    ืื™ืš ืื ื™ ื™ื›ื•ืœ ืœืขื–ื•ืจ ืœืš How can I help you:


    ืืคืฉืจ ืœืงื‘ืœ ืืช ื‘ื“ื™ืงื•ืช ื”ื“ื ื”ื—ืจื™ื’ื•ืช ืฉืœืš Exceptional laboratory tests:


    ใ”ๆณจๆ„ใใ ใ•ใ„๏ผš

    ใ”่‡ช่บซใ€ใพใŸใฏใ”ๅฎถๆ—ใฎๅฅๅบท็Šถๆ…‹ใซ้–ข้€ฃใ™ใ‚‹ใ™ในใฆใฎ่ฃฝๅ“๏ผˆ้ฃŸๅ“ใ€ๆŠฝๅ‡บ็‰ฉใ€ใ‚ตใƒ—ใƒชใƒกใƒณใƒˆใ€ใ‚ฏใƒชใƒผใƒ ใ€้‹ๅ‹•ใชใฉ๏ผ‰ใ‚’ใ”ไฝฟ็”จใซใชใ‚‹ๅ‰ใซใ€ๅฟ…ใšไฟก้ ผใงใใ‚‹ๅŒปๅธซใพใŸใฏ่–ฌๅ‰คๅธซใซใ”็›ธ่ซ‡ใใ ใ•ใ„ใ€‚

    ใƒคใƒญใƒณใƒปใƒžใƒซใ‚ดใƒชใƒณใฏๅ…ƒใƒ€ใƒณใ‚ตใƒผใงใ‚ใ‚Šใ€1980ๅนดไปฃๅŠใฐใซใ‚จใƒซใ‚ตใƒฌใƒ ใง็‹ฌ่‡ชใฎ่บซไฝ“ใ‚ขใƒ—ใƒญใƒผใƒใ‚’ๅฑ•้–‹ใ—ใพใ—ใŸใ€‚
    ่ˆžๅฐใ‹ใ‚‰ๅผ•้€€ๅพŒใฏใ€ๆ…ขๆ€ง็–พๆ‚ฃใ€็‰นใซ่…ŽๆฉŸ่ƒฝใซ้–ขใ™ใ‚‹ๅฎŸ่ทต็š„ใชๅ–ใ‚Š็ต„ใฟใซ้–ขใ‚ใ‚‹ใ‚ˆใ†ใซใชใ‚Šใ€่บซไฝ“ใซๆœฌๆฅๅ‚™ใ‚ใ‚‹่ชฟ็ฏ€ใƒปๅ›žๅพฉใƒกใ‚ซใƒ‹ใ‚บใƒ ใซ็€็›ฎใ—ใŸ่ฆ–็‚นใ‚’็™บๅฑ•ใ•ใ›ใฆใใพใ—ใŸใ€‚
    ๅฝผใฎใ‚ขใƒ—ใƒญใƒผใƒใฏใ€ๅพ“ๆฅใฎๆฒป็™‚ใ‚’็ฝฎใๆ›ใˆใ‚‹ใ‚‚ใฎใงใฏใชใใ€็”Ÿไฝ“ๅ†…ใฎ็ถญๆŒใƒป่ชฟๆ•ดๆฉŸๆง‹ใ‚’็†่งฃใ™ใ‚‹ใŸใ‚ใฎ่ฃœๅฎŒ็š„ใชๆž ็ต„ใฟใจใ—ใฆไฝ็ฝฎใฅใ‘ใ‚‰ใ‚Œใฆใ„ใพใ™ใ€‚

    ๅฝผใฎใ‚ฆใ‚งใƒ–ใ‚ตใ‚คใƒˆ๏ผˆYARONMARGOLIN.COM๏ผ‰ใ€ใƒ•ใ‚งใ‚คใ‚นใƒ–ใƒƒใ‚ฏใƒšใƒผใ‚ธใ€Œ็™’ใ—ใฎๅœงๆณ•ใ€ใ‚„ๆœฌ่จ˜ไบ‹ใ€ใŠใ‚ˆใณใใฎไป–ใฎ่ซ–ๆ–‡ใซ่จ˜่ผ‰ใ•ใ‚Œใฆใ„ใ‚‹ๆƒ…ๅ ฑใฏใ€ใ€Œ่€ƒๅฏŸใฎใŸใ‚ใฎๅ“ฒๅญฆ็š„่ณ‡ๆ–™ใ€ใงใ‚ใ‚Šใ€ๅŒป็™‚ไธŠใฎๆŽจๅฅจใ‚„ๆŒ‡ๅฐŽใงใฏใ‚ใ‚Šใพใ›ใ‚“ใ€‚

    ใ“ใฎใ‚ตใ‚คใƒˆใ€ใพใŸใฏ้–ข้€ฃใ™ใ‚‹ใ™ในใฆใฎ่ณ‡ๆ–™ใฏใ€ๅ‡ฆๆ–น่–ฌใฎไฝฟ็”จใพใŸใฏไธญๆญขใซ้–ขใ™ใ‚‹ไปฃๆ›ฟใจใชใ‚‹ใ‚‚ใฎใงใฏใชใใ€ๅฅๅบทใซ้–ขใ—ใฆๆฑบๅฎšใ‚’่กŒใ†ใŸใ‚ใฎๅ”ฏไธ€ใฎๆƒ…ๅ ฑๆบใจใ™ในใใงใฏใ‚ใ‚Šใพใ›ใ‚“ใ€‚

    ไธ่ชฟใ€็—›ใฟใ€ไฝฟ็”จ็›ฎ็š„ใซ้–ขใ—ใฆใฏใ€ๅธธใซ่ณ‡ๆ ผใฎใ‚ใ‚‹ๅฐ‚้–€ๅŒปใพใŸใฏ่–ฌๅ‰คๅธซใจ็›ธ่ซ‡ใ—ใฆใใ ใ•ใ„ใ€‚


    ใ“ใฎใƒ†ใƒผใƒžใซ้–ขใ™ใ‚‹ใƒคใƒญใƒณใƒปใƒžใƒผใ‚ดใƒชใƒณใซใ‚ˆใ‚‹ใƒ˜ใƒ–ใƒฉใ‚ค่ชžใจ่‹ฑ่ชžใฎ่จ˜ไบ‹

    ืื—ืจื•ื ื™ื


    ื ืฉืœื— ื‘ ื›ืœืœื™

    ื›ืชื™ื‘ืช ืชื’ื•ื‘ื”

    Or

    ื”ืื™ืžื™ื™ืœ ืœื ื™ื•ืฆื’ ื‘ืืชืจ. ืฉื“ื•ืช ื”ื—ื•ื‘ื” ืžืกื•ืžื ื™ื *

    *